BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 7530001)

  • 1. Functional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cells.
    Nakane M; Pollock JS; Klinghofer V; Basha F; Marsden PA; Hokari A; Ogura T; Esumi H; Carter GW
    Biochem Biophys Res Commun; 1995 Jan; 206(2):511-7. PubMed ID: 7530001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel potent and selective inhibitors of inducible nitric oxide synthase.
    Nakane M; Klinghofer V; Kuk JE; Donnelly JL; Budzik GP; Pollock JS; Basha F; Carter GW
    Mol Pharmacol; 1995 Apr; 47(4):831-4. PubMed ID: 7536889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
    Joly GA; Ayres M; Chelly F; Kilbourn RG
    Biochem Biophys Res Commun; 1994 Feb; 199(1):147-54. PubMed ID: 7510104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme requirement for production of active endothelial nitric oxide synthase in baculovirus-infected insect cells.
    Seo HG; Fujii J; Soejima H; Niikawa N; Taniguchi N
    Biochem Biophys Res Commun; 1995 Mar; 208(1):10-8. PubMed ID: 7534070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant endothelial nitric oxide synthase: post-translational modifications in a baculovirus expression system.
    Busconi L; Michel T
    Mol Pharmacol; 1995 Apr; 47(4):655-9. PubMed ID: 7536885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages.
    Baydoun AR; Mann GE
    Biochem Biophys Res Commun; 1994 Apr; 200(2):726-31. PubMed ID: 7513994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
    Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
    Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
    Schmidt K; Klatt P; Mayer B
    Mol Pharmacol; 1993 Sep; 44(3):615-21. PubMed ID: 7690451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes.
    Nussler AK; Di Silvio M; Liu ZZ; Geller DA; Freeswick P; Dorko K; Bartoli F; Billiar TR
    Hepatology; 1995 Jun; 21(6):1552-60. PubMed ID: 7539395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate and substrate analog binding to endothelial nitric oxide synthase: electron paramagnetic resonance as an isoform-specific probe of the binding mode of substrate analogs.
    Salerno JC; Martásek P; Williams RF; Masters BS
    Biochemistry; 1997 Sep; 36(39):11821-7. PubMed ID: 9305973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nitric oxide synthase specific autophosphorylation in baculovirus/Sf9 insect cell system.
    Watanabe Y; Terashima K; Hidaka H
    Biochem Biophys Res Commun; 1996 Feb; 219(2):638-43. PubMed ID: 8605040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
    Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
    J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between different isoforms of nitric oxide synthase and cyclooxygenase in various cell types.
    Swierkosz TA; Mitchell JA; Tomlinson A; Botting RM; Warner TD; Vane JR
    Pol J Pharmacol; 1994; 46(6):587-92. PubMed ID: 7542521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
    Chang MJ; Modzelewski RA; Russell DM; Johnson CS
    Cancer Res; 1996 Feb; 56(4):886-91. PubMed ID: 8631029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
    Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
    Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of osteoblast growth by nitric oxide synthase inhibitors: an effect independent of nitric oxide and arginine transport inhibition.
    Riancho JA; Zarrabeitia MT; Salas E; González-Macías J
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):663-7. PubMed ID: 9121222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms.
    Chen LY; Mehta JL
    J Pharmacol Exp Ther; 1996 Jan; 276(1):253-7. PubMed ID: 8558439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of a rat neuronal nitric oxide synthase coding sequence in a baculovirus/insect cell system.
    Charles IG; Chubb A; Gill R; Clare J; Lowe PN; Holmes LS; Page M; Keeling JG; Moncada S; Riveros-Moreno V
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1481-9. PubMed ID: 7504478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
    Wolff DJ; Lubeskie A
    Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.